Clinical trials · New York, NY
Giant Cell Arteritis clinical trials in New York
We’re tracking 3 recruiting giant cell arteritis studies with a site in or near New York — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT04474847RecruitingPhase 3
Abatacept for giant cell arteritis treatment
This Phase 3 trial tests abatacept to treat giant cell arteritis (GCA), a blood vessel inflammation that can cause headaches and vision risk. It’s for people with newly diagnosed or returning (relapsing) GCA with active symptoms in the last 8 weeks.
New York, New YorkAges 50 years+ - NCT07108387RecruitingPhase 2
Stopping or reducing tocilizumab for well-controlled giant cell arteritis
This study compares stopping tocilizumab (Actemra) completely versus reducing the dose in people whose giant cell arteritis has been well controlled for at least a year. The goal is to find out which approach keeps the disease in remission while reducing medication side effects.
New York, New YorkAges 50 years+ - NCT01241305Recruiting
One-Time DNA Study for Different Types of Vasculitis
This trial collects a one-time DNA sample to better understand vasculitis, which are illnesses where blood vessels become inflamed. It may help researchers find why these conditions happen and how they differ across people.
New York, New YorkAges 7 years+
Hear when a new Giant Cell Arteritis trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Giant Cell Arteritis trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting giant cell arteritis studies listed above.
- Hospital for Special Surgery · 3 studies
- Northwell Health
What taking part in a giant cell arteritis study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting giant cell arteritis studies in New York.
Common questions
- Are there giant cell arteritis clinical trials near New York?
- Yes. We're currently tracking 3 recruiting giant cell arteritis studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a giant cell arteritis study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a giant cell arteritis trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New giant cell arteritis studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.